Does Social Media Impact Adolescent Mental Health?

ConditionMental Health
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-14
SponsorGeorgetown University

About this trial

The mental health of adolescents in the United States has seen a steep decline, roughly coinciding with the increasing popularity of social media and smartphones. But does social media have a causal impact on the mental health of adolescents or are concerns about the effect of social media on kids a form of public hysteria? In this study, the investigators will conduct the first field experiment in 10-14-year-olds to examine whether, how, and for whom social media harms mental health.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

is an adolescent who is between the ages of 10 and 14;

is an adolescent whose parents have decided to buy them their first smartphone;

is an adolescent both of whose parents/guardians consent for them to be in the study;

is an adolescent who assents to be in the study; 5) is an adolescent who speaks and reads English sufficiently to complete surveys and provide informed consent.

Disqualifiers

is an adolescent who has severe developmental problems (e.g., autism, severe language delay);

is an adolescent who is currently or has ever been diagnosed with severe or moderately severe mental illness;

is an adolescent who is currently or has ever experienced suicidal ideation.

Trial design

Design model

Crossover

Treatments tested in this trial

  • Restricted Social Media

    Behavioral

    Participants (N = 500) will be randomly assigned to either have no study-imposed restrictions on social media use (naturalistic social media condition) or have no access to social media apps on their phones (restricted social media condition). This manipulation will last three months, after which both groups will have no study-imposed restrictions on social media for three more months.

Treatment groups

500 Participants
are divided into 2 treatment groups
Group A: Naturalistic Social MediaNo intervention 0 interventions
Group B: Restricted Social MediaExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Revised Child Anxiety and Depression Scale (RCADS-25): Total Score

The average score varies between 0 and 4, with higher scores indicating a worse outcome.

Time frame
Baseline, three months, and six months

Secondary outcomes

1

Revised Child Anxiety and Depression Scale (RCADS-25): Depression Subscale

The average score varies between 0 and 4, with higher scores indicating a worse outcome.

Time frame
Baseline, three months, and six months
2

Revised Child Anxiety and Depression Scale (RCADS-25): Anxiety Subscale

The average score varies between 0 and 4, with higher scores indicating a worse outcome.

Time frame
Baseline, three months, and six months

Other outcomes

1

DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure Youth Self Report

The average score varies between 0 and 4, with higher scores indicating a worse outcome.

Time frame
Baseline, three months, and six months
2

DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure Parent Report

The average score varies between 0 and 4, with higher scores indicating a worse outcome.

Time frame
Baseline, three months, and six months
3

Upward Social Comparison (EMA)

Mediator measured with a single, face-valid item in EMA surveys: "Over the past 24 hours, how often have you compared yourself to someone who you believe is better off than you?"

Time frame
Every three days throughout the study with two averages computed for 0 to 3 months and 3 to 6 months.
4

Offline Social Capital: Quantity of In-Person Social Interactions (EMA)

Mediator measured with a single, face-valid item in EMA surveys: "Over past 24 hours, how much time did you spend socializing in person?"

Time frame
Every three days throughout the study with two averages computed for 0 to 3 months and 3 to 6 months.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Georgetown University

Lead sponsor

National Institutes of Health (NIH)

Collaborator